Confirmed diagnosis of classic Wiskott-Aldrich syndrome in East Africa: a case report.
Case report
Eczema
Micro thrombocytopenia
Wiskott-Aldrich syndrome
Wiskott-Aldrich syndrome protein
Journal
Journal of medical case reports
ISSN: 1752-1947
Titre abrégé: J Med Case Rep
Pays: England
ID NLM: 101293382
Informations de publication
Date de publication:
27 Jul 2022
27 Jul 2022
Historique:
received:
22
10
2020
accepted:
01
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
30
7
2022
Statut:
epublish
Résumé
Wiskott-Aldrich syndrome is a rare X-linked primary immunodeficiency that mostly presents with a classic triad of eczema, microthrombocytopenia, recurrent infections, and increased risk of autoimmunity/malignancies. We present an 8-month-old African male, born from nonconsanguineous parents and who presented with a history of eczematous skin rash since day 9 of life, with recurrent sinus infections, otitis media, and skin abscesses. An elder male sibling who had similar symptoms passed away during infancy. Investigations were consistent with microthrombocytopenia and significantly raised immunoglobulin E, while immunoglobulin A and immunoglobulin G were moderately elevated with normal immunoglobulin M. Genetic testing revealed the patient to be hemizygous for a pathogenic Wiskott-Aldrich syndrome gene variant (NM_000377.2:c.403C>T). He was managed conservatively with supportive treatment until he died a year later. Despite Wiskott-Aldrich syndrome being a rare disease, it should be considered as a differential in any male child who presents with microthrombocytopenia and recurrent infections, especially in low-resource settings where genetic testing is not routinely available.
Identifiants
pubmed: 35897083
doi: 10.1186/s13256-022-03517-1
pii: 10.1186/s13256-022-03517-1
pmc: PMC9327242
doi:
Substances chimiques
Immunoglobulin G
0
Wiskott-Aldrich Syndrome Protein
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
301Informations de copyright
© 2022. The Author(s).
Références
J Pediatr. 1994 Dec;125(6 Pt 1):876-85
pubmed: 7996359
Clin Immunol. 2003 Dec;109(3):272-7
pubmed: 14697741
Pediatrics. 2003 May;111(5 Pt 1):e622-7
pubmed: 12728121
Appl Clin Genet. 2014 Apr 03;7:55-66
pubmed: 24817816
BMC Med Genet. 2020 Jun 5;21(1):124
pubmed: 32503528
Blood. 1997 Oct 1;90(7):2680-9
pubmed: 9326235
Br J Haematol. 2006 Nov;135(3):362-6
pubmed: 17032176
Immunobiology. 2009;214(9-10):778-90
pubmed: 19628299
J Clin Immunol. 2000 Nov;20(6):477-85
pubmed: 11202238
S Afr Med J. 1965 Apr 10;39:280-2
pubmed: 14286613
Arch Dis Child. 1996 Nov;75(5):436-9
pubmed: 8957959
Ethiop J Health Sci. 2020 Nov;30(6):1051-1054
pubmed: 33883853
Biol Blood Marrow Transplant. 2009 Jan;15(1 Suppl):84-90
pubmed: 19147084
Cell. 1994 Aug 26;78(4):635-44
pubmed: 8069912
Bone Marrow Transplant. 2012 Nov;47(11):1428-35
pubmed: 22426750
J Clin Immunol. 2005 Jan;25(1):73-7
pubmed: 15742160
Blood. 2011 Aug 11;118(6):1675-84
pubmed: 21659547
Blood. 2008 Jan 1;111(1):439-45
pubmed: 17901250
Lancet Haematol. 2019 May;6(5):e230-e231
pubmed: 30981782